Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P J Hunt

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Wellcome Open Research|February 15, 2021
Impact of the first COVID-19 pandemic wave on the Scottish Multiple Sclerosis Register populationPeter M Fernandes, Martin O'Neill, Patrick K A Kearns, et al.
Rheumatology (Oxford, England)|November 26, 2024
Elevated serum interferon-α2 associates with activity and flare risk in juvenile-onset systemic lupus erythematosusValentina Natoli, Yanick J Crow, David P J Hunt, et al.
Nature Communications|January 27, 2026
Oligoprotein type I interferon signatures, but not TREX1 variants, increase risk of systemic lupus erythematosus in UK BiobankBastien Rioux, Sarah McGlasson, Deborah Forbes, et al.
Wellcome Open Research|February 2, 2018
Rare variants of the 3'-5' DNA exonuclease <i>TREX1</i> in early onset small vessel strokeSarah McGlasson, Kristiina Rannikmäe, Steven Bevan, et al.
Brain Communications|December 8, 2021
MRI-derived g-ratio and lesion severity in newly diagnosed multiple sclerosisElizabeth N York, Sarah-Jane Martin, Rozanna Meijboom, et al.
Neuroradiology|October 19, 2021
Rim lesions are demonstrated in early relapsing-remitting multiple sclerosis using 3 T-based susceptibility-weighted imaging in a multi-institutional settingKoy Chong Ng Kee Kwong, Daisy Mollison, Rozanna Meijboom, et al.
Nature Communications|May 27, 2024
Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in EnglandEmma Copland, Martina Patone, Defne Saatci, et al.
Plos One|July 28, 2023
Patterns of brain atrophy in recently-diagnosed relapsing-remitting multiple sclerosisRozanna Meijboom, Elizabeth N York, Agniete Kampaite, et al.
Brain : a Journal of Neurology|June 6, 2025
Misdirected yet intact TREX1 exonuclease activity causes human cerebral and systemic small vessel diseaseSarah McGlasson, Katy Reid, Anna Klingseisen, et al.
Immunity|June 15, 2024
The brain microvasculature is a primary mediator of interferon-α neurotoxicity in human cerebral interferonopathiesBarney Viengkhou, Emina Hayashida, Sarah McGlasson, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Wellcome Open Research|February 15, 2021
Impact of the first COVID-19 pandemic wave on the Scottish Multiple Sclerosis Register populationPeter M Fernandes, Martin O'Neill, Patrick K A Kearns, et al.
Rheumatology (Oxford, England)|November 26, 2024
Elevated serum interferon-α2 associates with activity and flare risk in juvenile-onset systemic lupus erythematosusValentina Natoli, Yanick J Crow, David P J Hunt, et al.
Nature Communications|January 27, 2026
Oligoprotein type I interferon signatures, but not TREX1 variants, increase risk of systemic lupus erythematosus in UK BiobankBastien Rioux, Sarah McGlasson, Deborah Forbes, et al.
Wellcome Open Research|February 2, 2018
Rare variants of the 3'-5' DNA exonuclease <i>TREX1</i> in early onset small vessel strokeSarah McGlasson, Kristiina Rannikmäe, Steven Bevan, et al.
Brain Communications|December 8, 2021
MRI-derived g-ratio and lesion severity in newly diagnosed multiple sclerosisElizabeth N York, Sarah-Jane Martin, Rozanna Meijboom, et al.
Neuroradiology|October 19, 2021
Rim lesions are demonstrated in early relapsing-remitting multiple sclerosis using 3 T-based susceptibility-weighted imaging in a multi-institutional settingKoy Chong Ng Kee Kwong, Daisy Mollison, Rozanna Meijboom, et al.
Nature Communications|May 27, 2024
Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in EnglandEmma Copland, Martina Patone, Defne Saatci, et al.
Plos One|July 28, 2023
Patterns of brain atrophy in recently-diagnosed relapsing-remitting multiple sclerosisRozanna Meijboom, Elizabeth N York, Agniete Kampaite, et al.
Brain : a Journal of Neurology|June 6, 2025
Misdirected yet intact TREX1 exonuclease activity causes human cerebral and systemic small vessel diseaseSarah McGlasson, Katy Reid, Anna Klingseisen, et al.
Immunity|June 15, 2024
The brain microvasculature is a primary mediator of interferon-α neurotoxicity in human cerebral interferonopathiesBarney Viengkhou, Emina Hayashida, Sarah McGlasson, et al.
Pageof 3